CardioFocus Announces European CE Mark Approval Of The Next-Generation HeartLight Excalibur Balloon Designed For The Treatment Of Atrial Fibrillation Post author:Sam Post published:September 26, 2017 Post category:BioPharma Life Sciences Jobs … Source: BioSpace You Might Also Like FDA Rejects Agile's Contraceptive Patch Twirla For a Second Time December 21, 2017 Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017 Massachusetts' Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring March 29, 2017
Rexahn Pharmaceuticals, Inc. Announces Retirement Of Its Founder, From The Board Of Directors August 31, 2017
Massachusetts' Agenus to Phase Out 20% of Jobs, Shutter Switzerland Facility in Restructuring March 29, 2017